MA
GILD icon

Modus Advisors’s Gilead Sciences GILD Stock Holding History

Modus Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$707K Sell
5,597
-287
-5% -$37.8K 0.17% 85
2026
Q1 		$820K Sell
5,884
-2,959
-33% -$414K 0.23% 78
2025
Q4 		$1.09M Sell
8,843
-2,812
-24% -$342K 0.29% 78
2025
Q3 		$1.29M Buy
11,655
+478
+4% +$54.3K 0.35% 67
2025
Q2 		$1.24M Buy
11,177
+78
+0.7% +$8.3K 0.37% 64
2025
Q1 		$1.24M Buy
11,099
+125
+1% +$12.9K 0.41% 63
2024
Q4 		$1.01M Buy
10,974
+487
+5% +$43.8K 0.32% 65
2024
Q3 		$879K Buy
10,487
+677
+7% +$51.7K 0.29% 67
2024
Q2 		$673K Buy
9,810
+960
+11% +$64.1K 0.24% 69
2024
Q1 		$648K Buy
8,850
+966
+12% +$74.3K 0.24% 70
2023
Q4 		$639K Buy
7,884
+1,650
+26% +$128K 0.26% 66
2023
Q3 		$467K Buy
6,234
+588
+10% +$45.2K 0.2% 77
2023
Q2 		$435K Buy
5,646
+491
+10% +$39.2K 0.19% 75
2023
Q1 		$428K Buy
5,155
+61
+1% +$5.05K 0.2% 70
2022
Q4 		$437K Buy
5,094
+1,058
+26% +$83.8K 0.21% 69
2022
Q3 		$249K Buy
4,036
+28
+0.7% +$1.77K 0.13% 87
2022
Q2 		$248K Buy
4,008
+187
+5% +$11.6K 0.13% 84
2022
Q1 		$227K Buy
3,821
+792
+26% +$50.6K 0.1% 91
2021
Q4 		$220K Buy
+3,029
New +$209K 0.09% 94
2021
Q3 		– Sell
-1,628
Closed -$112K – 151
2021
Q2 		$112K Buy
+1,628
New +$109K 0.05% 118
2020
Q3 		– Sell
-499
Closed -$38K – 132
2020
Q2 		$38K Buy
+499
New +$38.2K 0.02% 132

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Modus Advisors's GILD Position: Q2 2026 in Review

Modus Advisors reduced its Gilead Sciences (GILD) stake by 4.9% in Q2 2026, selling an estimated $37.8K and leaving 5,597 shares worth $707K. The position accounts for 0.17% of the portfolio, ranked #85.

Modus Advisors first reported a position in GILD in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.29M in Q3 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Modus Advisors held 5,597 shares of Gilead Sciences worth $707K as of Q2 2026.
  • Modus Advisors sold 287 Gilead Sciences shares in Q2 2026, an estimated $37.8K.
  • Gilead Sciences made up 0.17% of Modus Advisors's portfolio in Q2 2026, its #85 holding.
  • Modus Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 21 quarters since.
  • Modus Advisors's Gilead Sciences position peaked at $1.29M in Q3 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Modus Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.